MINORYX Trademark

Trademark Overview

On Wednesday, October 28, 2015, a trademark application was filed for MINORYX with the United States Patent and Trademark Office. The USPTO has given the MINORYX trademark a serial number of 79179921. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Tuesday, January 28, 2025. This trademark is owned by Minoryx Therapeutics, S.L.. The MINORYX trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

[ pharmaceutical products for human use for the treatment of rare diseases; diagnostic preparations for medical use; all of the foregoing excluding pharmaceutical and diagnostic products for dentistry use; all of the foregoing excluding dietary and nutritional supplements ]

[ Medical services ]

scientific and technological services, namely, scientific research in the field of rare diseases and research and design relating thereto; research and development services and drug discovery services, all for new techniques for medical diagnosis and medicines [ , and design and development of software relating thereto ] ; research and development services and drug discovery services in the field of human health care
minoryx

General Information

Serial Number79179921
Word MarkMINORYX
Filing DateWednesday, October 28, 2015
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateTuesday, January 28, 2025
Registration Number5521544
Registration DateTuesday, July 24, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements

Goods and Services[ pharmaceutical products for human use for the treatment of rare diseases; diagnostic preparations for medical use; all of the foregoing excluding pharmaceutical and diagnostic products for dentistry use; all of the foregoing excluding dietary and nutritional supplements ]
Goods and Services[ Medical services ]
Goods and Servicesscientific and technological services, namely, scientific research in the field of rare diseases and research and design relating thereto; research and development services and drug discovery services, all for new techniques for medical diagnosis and medicines [ , and design and development of software relating thereto ] ; research and development services and drug discovery services in the field of human health care

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateTuesday, January 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 5, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateTuesday, January 28, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMinoryx Therapeutics, S.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMataró E-08302
ES
Party NameMinoryx Therapeutics, S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES
Party NameMinoryx Therapeutics, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events

Event DateEvent Description
Sunday, January 3, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, January 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 9, 2016APPLICATION FILING RECEIPT MAILED
Saturday, February 20, 2016ASSIGNED TO EXAMINER
Saturday, February 20, 2016NON-FINAL ACTION WRITTEN
Sunday, February 21, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 22, 2016REFUSAL PROCESSED BY MPU
Monday, February 22, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 11, 2016REFUSAL PROCESSED BY IB
Tuesday, August 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 6, 2016ASSIGNED TO LIE
Thursday, August 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 1, 2016FINAL REFUSAL WRITTEN
Thursday, September 1, 2016FINAL REFUSAL E-MAILED
Thursday, September 1, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, March 1, 2017EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, March 1, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, March 1, 2017EX PARTE APPEAL-INSTITUTED
Wednesday, March 1, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, March 3, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, March 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 11, 2017SUBSEQUENT FINAL REFUSAL WRITTEN
Saturday, March 11, 2017SUBSEQUENT FINAL EMAILED
Saturday, March 11, 2017NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, May 31, 2017NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, May 31, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, June 16, 2017NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, September 6, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, September 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 4, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 4, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2017OPPOSITION PAPERS RECEIVED AT TTAB
Wednesday, October 25, 2017OPPOSITION NOTICE (IB REFUSAL) CREATED
Wednesday, October 25, 2017OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Monday, October 30, 2017OPPOSITION INSTITUTED NO. 999999
Friday, November 17, 2017NOTIFICATION PROCESSED BY IB
Friday, November 17, 2017REFUSAL PROCESSED BY IB
Monday, November 20, 2017EXPARTE APPEAL TERMINATED
Thursday, June 14, 2018OPPOSITION DISMISSED NO. 999999
Thursday, June 14, 2018OPPOSITION TERMINATED NO. 999999
Thursday, June 14, 2018TTAB RELEASE CASE TO TRADEMARKS
Tuesday, July 24, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, October 24, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, November 9, 2018FINAL DISPOSITION PROCESSED
Friday, November 9, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 30, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 24, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, July 24, 2024TEAS SECTION 71 RECEIVED
Monday, January 27, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 28, 2025REGISTERED - PARTIAL SEC 71 ACCEPTED
Tuesday, January 28, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, September 11, 2025INTERNATIONAL REGISTRATION RENEWED
Sunday, September 28, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, December 9, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 9, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 9, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, December 9, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

minoryx services research medical development pharmaceutical field relating discovery drug thereto